Related Experiment Videos
Studies in hypoglycaemia in children with insulin-dependent diabetes mellitus
1Department of Medicine, Kings's College School of Medicine and Dentistry, London, UK.
Insights
Hypoglycaemia, a side effect of insulin therapy in children with diabetes, presents unique challenges due to developing counterregulatory responses. Avoiding low blood sugar is crucial for stable diabetes management and preventing severe events.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Hypoglycaemia is a primary acute complication of insulin therapy in pediatric diabetes.
- Children exhibit distinct counterregulatory hormone responses to low blood glucose compared to adults.
- Pubertal changes and recurrent hypoglycaemia can impair hormonal responses and destabilize diabetes control.
Purpose of the Study:
- To review the physiological responses to hypoglycaemia in children with diabetes.
- To discuss the implications of these responses for diabetes management and patient safety.
- To highlight strategies for preventing and managing hypoglycaemia in this population.
Main Methods:
- Literature review of pediatric endocrinology and diabetes research.
- Analysis of counterregulatory hormone responses in children versus adults.
- Examination of factors contributing to unstable diabetes control in youth.
Main Results:
- Children's counterregulatory hormone responses to hypoglycaemia differ from adults, with potential loss of glucagon response but preserved catecholamine, cortisol, and growth hormone responses.
- Younger children may exhibit fewer or less pronounced autonomic symptoms of hypoglycaemia.
- Recurrent hypoglycaemia can lead to impaired counterregulatory responses, increasing severe hypoglycaemia risk.
- While the brain may utilize alternative fuels during hypoglycaemia, clinical strategies focus on avoidance.
Conclusions:
- Preventing moderate hypoglycaemia is key to restoring normal warning symptoms and improving diabetes management in children.
- Current clinical practice emphasizes proactive avoidance of hypoglycaemia as the primary protective measure.
- Further research into alternative fuel utilization by the brain is needed but not yet clinically applicable.
Abstract:
Hypoglycaemia is the most important acute side effect of insulin therapy for diabetes in children. In general, children have more vigorous counterregulatory hormone responses to hypoglycaemia than adults. Children with diabetes may lose their glucagon responses to a falling blood glucose but persistence of brisk catecholamine, cortisol and growth hormone responses, coupled with the insulin resistance natural to puberty, may contribute to unstable diabetes control. Despite this, there is some evidence that younger children may not experience or at least express autonomic symptoms to the same degree as do adults. Furthermore, recurrent hypoglycaemia may induce defects in the counterregulatory responses and increase the risk of severe hypoglycaemia. Avoidance of moderate hypoglycaemia in clinical management may restore normal warning. There is research evidence to suggest that the human brain may be able to use non-glucose fuels to support its metabolism and function during hypoglycaemia but this is not yet translatable into clinical practice and care to avoid hypoglycaemia in daily life remains the patients' best protection.